Nathan Rice
Stock Analyst at Piper Sandler
(3.10)
# 1,172
Out of 5,127 analysts
61
Total ratings
52.63%
Success rate
11.6%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFC Bank First | Maintains: Neutral | $142 → $150 | $151.62 | -1.07% | 10 | Jan 26, 2026 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $44.13 | +8.77% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $45.06 | -6.79% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $33.52 | +4.42% | 9 | Oct 28, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $75.77 | -2.34% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $153.32 | -45.21% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $192.50 | +2.34% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $24.83 | -63.75% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $639.79 | -32.01% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $294.40 | -20.86% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $38.04 | +118.19% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $21.11 | -28.94% | 1 | Dec 19, 2019 |
Bank First
Jan 26, 2026
Maintains: Neutral
Price Target: $142 → $150
Current: $151.62
Upside: -1.07%
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $44.13
Upside: +8.77%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $45.06
Upside: -6.79%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $33.52
Upside: +4.42%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $75.77
Upside: -2.34%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $153.32
Upside: -45.21%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $192.50
Upside: +2.34%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $24.83
Upside: -63.75%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $639.79
Upside: -32.01%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $294.40
Upside: -20.86%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $38.04
Upside: +118.19%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $21.11
Upside: -28.94%